NeueHealthNEUE
NEUE
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
44% more capital invested
Capital invested by funds: $27.1M [Q3] → $39M (+$11.8M) [Q4]
25% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 5 (+1) [Q4]
6% more funds holding
Funds holding: 36 [Q3] → 38 (+2) [Q4]
0.83% more ownership
Funds ownership: 62.81% [Q3] → 63.64% (+0.83%) [Q4]
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Research analyst outlook
We haven’t received any recent analyst ratings for NEUE.
Financial journalist opinion
Neutral
Seeking Alpha
1 week ago
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
NeueHealth, Inc (NYSE:NEUE ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Operator Good morning, and thank you for joining us for the NeueHealth Q4 2024 Earnings Conference Call. My name is Carlin.
Neutral
Business Wire
1 week ago
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. “In 2024, we delivered our strongest financial performance to date, demonstrating the power of our value-driven, consumer-centric care model,” said Mike Mikan, President and CEO of NeueHealth. “We have established a strong foundation to drive strategic growth in 2025 with a.
Neutral
Business Wire
1 month ago
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025
DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report fourth quarter and full year 2024 financial results before the financial markets open on Thursday, March 20, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, in.
Neutral
PRNewsWire
1 month ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into NeueHealth Inc. ("NEUE").
NEW YORK , Feb. 11, 2025 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own NeueHealth Inc. ("NEUE" or the "Company") (NYSE: NEUE) stock purchased on or before December 22 , 2024 . Levi & Korsinsky, LLP has commenced an investigation into potential breaches of fiduciary duty by the NEUE board of directors.
Neutral
PRNewsWire
1 month ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEUE, ESSA, LTRPA on Behalf of Shareholders
NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: NeueHealth, Inc. (NYSE: NEUE)'s sale to an affiliate of New Enterprise Associates for $7.33 per share in cash. If you are a NeueHealth shareholder, click here to learn more about your rights and options.
Neutral
Accesswire
1 month ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
Neutral
Accesswire
1 month ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeueHealth, Inc. (NEUE) And Encourages Shareholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
Neutral
Accesswire
1 month ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeueHealth, Inc. (NEUE) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
Neutral
Accesswire
2 months ago
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
Neutral
Accesswire
2 months ago
The Schall Law Firm Invites Investors With Losses To Join An Investigation Into NeueHealth, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / January 29, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
Charts implemented using Lightweight Charts™